贝康医疗-B(02170)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

02170 贝康医疗-B

已收盘 04-09 16:08:11

2.050

-0.050

-2.38%

最高2.060	最低1.960	成交量6.20万
今开2.060	昨收2.100	日振幅4.76%
总市值5.61亿	流通市值1.70亿	总股本2.74亿
成交额12.57万	换手率0.07%	流通股本8,271万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"02170","market":"HK","secType":"STK","nameCN":"贝康医疗-B","latestPrice":2.05,"timestamp":1775722091587,"preClose":2.1,"halted":0,"volume":62000,"delay":0,"changeRate":-0.023809523809523937,"floatShares":82713835,"shares":273526000,"eps":-0.9361971121957332,"marketStatus":"已收盘","change":-0.05,"latestTime":"04-09 16:08:11","open":2.06,"high":2.06,"low":1.96,"amount":125720,"amplitude":0.047619,"askPrice":2.05,"askSize":17000,"bidPrice":1.97,"bidSize":11500,"shortable":0,"etf":0,"ttmEps":-0.9361971121957332,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1775784600000},"marketStatusCode":5,"adr":0,"listingDate":1612713600000,"exchange":"SEHK","adjPreClose":2.1,"openAndCloseTimeList":[[1775698200000,1775707200000],[1775710800000,1775721600000]],"volumeRatio":0.45858,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02170","defaultTab":"news","newsList":[{"id":"1148406290","title":"贝康医疗-B发布3月股份变动月报表，股本维持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1148406290","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1148406290?lang=zh_cn&edition=full","pubTime":"2026-04-09 16:43","pubTimestamp":1775724230,"startTime":"0","endTime":"0","summary":"苏州贝康医疗股份有限公司于2026年4月9日披露3月股份变动月报表，报告期截至2026年3月31日。根据公告，报告期内公司已发行股本结构保持不变，未发生新增发行、购回、注销或库藏股变动。根据月报，本月底法定/注册股本总额人民币273,526,000元。其中，H股已发行股份为82,713,835股，内资股为183,181,817股，未上市外资股为7,630,348股。上述各类股份数均与上月底保持一致，期内未见任何增减变动。本次公告由执行董事梁波签署。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02170"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625937512","title":"贝康医疗-B(02170)：受精培养液和囊胚培养液获国家药监局颁发医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2625937512","media":"智通财经","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2625937512?lang=zh_cn&edition=full","pubTime":"2026-04-07 19:29","pubTimestamp":1775561354,"startTime":"0","endTime":"0","summary":"智通财经APP讯，贝康医疗-B 发布公告，本公司Gems系列两款核心培养液产品 — 受精培养液和囊胚培养液于2026年4月2日双双获得国家药品监督管理局颁发的三类医疗器械注册证。此次获证的受精培养液与囊胚培养液，与今年2月已获批的Geri胚胎培养液、 2025年获批的胚胎处理液，共同构成了覆盖“受精→卵裂胚培养→囊胚培养”全流程的Gems全品系培养液矩阵。受精培养液专为卵母细胞和精子提供适宜的受精环境，以促进受精。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1425543.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1100","BK1583","BK1597","09996","BK1574","02170","159883","09997","BK1222"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1125689831","title":"贝康医疗-B(02170.HK) 受精培养基与囊胚培养基获国家药监局医疗器械注册证批准","url":"https://stock-news.laohu8.com/highlight/detail?id=1125689831","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1125689831?lang=zh_cn&edition=full","pubTime":"2026-04-07 18:44","pubTimestamp":1775558662,"startTime":"0","endTime":"0","summary":"苏州贝康医疗宣布，其两款核心产品——受精培养基与囊胚培养基，已正式获得国家药品监督管理局（NMPA）颁发的医疗器械注册证书。此次获批标志着公司在辅助生殖领域的研发实力与产品商业化进程取得重要突破，相关产品将有望进一步服务于国内生殖医学临床需求。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02170","BK1597","BK1222","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624639548","title":"贝康医疗：受精+囊胚培养液双双获证，辅助生殖国产替代迎来“王者回归”","url":"https://stock-news.laohu8.com/highlight/detail?id=2624639548","media":"格隆汇","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624639548?lang=zh_cn&edition=full","pubTime":"2026-04-03 09:37","pubTimestamp":1775180261,"startTime":"0","endTime":"0","summary":"当第一个拥有大规模临床试验数据的中国本土全品系培养液品牌强势归来，当国产替代从“概念”变为“现实”，贝康医疗无疑正处于价值发现的关键节点。","market":"sh","thumbnail":"https://img2.gelonghui.com/b17e2-5ff0c5e8-60db-45ba-8e64-4b183caf021d.jpg?guru_height=720&guru_width=1280&guru_size=154189","type":0,"news_type":0,"thumbnails":["https://img2.gelonghui.com/b17e2-5ff0c5e8-60db-45ba-8e64-4b183caf021d.jpg?guru_height=720&guru_width=1280&guru_size=154189"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/p/4291618","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"gelonghui_highlight","symbols":["BK1597","02170","BK1222","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623377568","title":"贝康医疗2025业绩亮点：从IVD到IVF全场景AI平台，成为中国辅助生殖领域行业龙头","url":"https://stock-news.laohu8.com/highlight/detail?id=2623377568","media":"格隆汇","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2623377568?lang=zh_cn&edition=full","pubTime":"2026-03-31 12:49","pubTimestamp":1774932592,"startTime":"0","endTime":"0","summary":"伴随国产智造与人工智能的双重浪潮，贝康医疗正以确定的盈利预期和坚实的竞争壁垒，叩响辅助生殖赛道价值重估的大门。","market":"fut","thumbnail":"https://img2.gelonghui.com/b17e2-5257232d-3843-4fee-aee1-cf4340bf53a5.jpg?guru_height=720&guru_width=1280&guru_size=154189","type":0,"news_type":0,"thumbnails":["https://img2.gelonghui.com/b17e2-5257232d-3843-4fee-aee1-cf4340bf53a5.jpg?guru_height=720&guru_width=1280&guru_size=154189"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/p/4247094","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"gelonghui_highlight","symbols":["BK1597","BK4082","CHAT","AGIX","IVF","BK1574","02170","AIPO","BK1222"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623328501","title":"贝康医疗-B(02170)发布年度业绩，收入2.33亿元 核心产品注册、国产化推进及平台型业务布局方面取得多项重要进展","url":"https://stock-news.laohu8.com/highlight/detail?id=2623328501","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2623328501?lang=zh_cn&edition=full","pubTime":"2026-03-31 01:24","pubTimestamp":1774891440,"startTime":"0","endTime":"0","summary":"智通财经APP讯，贝康医疗-B 发布截至2025年12月31日止年度业绩，该集团取得收入2.33亿元，同比减少22.01%;公司权益股东应占亏损2.23亿元，同比减少5.7%;每股亏损0.8元。2025年，对本集团而言，是由“研发及注册驱动”逐步迈向“商业化落地及经营优化驱动”的关键一年。报告期内，本集团在核心产品注册、国产化推进及平台型业务布局方面取得多项重要进展。于男科领域，家用精子检测设备获批上市，进一步完善本集团在辅助生殖前端检测场景的产品布局。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1422484.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"贝康医疗-B(02170)发布年度业绩，收入2.33亿元 核心产品注册、国产化推进及平台型业务布局方面取得多项重要进展","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1574","BK1222","02170","BK1597"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1164550073","title":"贝康医疗-BPGT-A检测试剂盒获中国药监局三类医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=1164550073","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1164550073?lang=zh_cn&edition=full","pubTime":"2026-03-16 20:35","pubTimestamp":1773664549,"startTime":"0","endTime":"0","summary":"贝康医疗-B（股票代码：02170）近日宣布，其自主研发的PGT-A检测试剂盒已正式获得中国国家药品监督管理局（NMPA）颁发的三类医疗器械注册证。这一重要进展标志着该产品在中国市场合规上市的关键一步，有望为辅助生殖领域提供更精准、可靠的检测工具。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1597","02170","BK1222","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619045006","title":"贝康医疗-B(02170)：PGT-A试剂盒获国家药监局颁发医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2619045006","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2619045006?lang=zh_cn&edition=full","pubTime":"2026-03-16 20:05","pubTimestamp":1773662722,"startTime":"0","endTime":"0","summary":"智通财经APP讯，贝康医疗-B 公布，公司基于国产高通量基因测序平台的 PGT-A试剂盒，胚胎植入前染色体非整倍体检测试剂盒，于2026年3月13日成功获批国家三类医疗器械注册证，成为全国首个基于纯国产自主平台测序仪的PGT-A试剂盒。PGT-A试剂盒透过筛检胚胎染色体非整倍体异常，能有效降低流产风险和出生缺陷发生率，是第三代试管婴儿技术的关键支撑。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1414485.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1222","159883","BK1100","09997","BK1583","BK1597","09996","02170","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618999172","title":"贝康医疗-B03月10日主力净流入18.8万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2618999172","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618999172?lang=zh_cn&edition=full","pubTime":"2026-03-10 16:15","pubTimestamp":1773130544,"startTime":"0","endTime":"0","summary":"03月10日, 贝康医疗-B股价涨7.57%，报收1.99元，成交金额28.8万元，换手率0.18%，振幅8.11%，量比2.14。贝康医疗-B今日主力资金净流入18.8万元，上一交易日主力净流出0万元。该股近5个交易日上涨9.94%，主力资金累计净流入36.6万元；近20日主力资金累计净流入62.1万元，其中净流入天数为4日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260310161854a6b4c7b8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260310161854a6b4c7b8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1222","02170","BK1574","BK1597"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1128578366","title":"贝康医疗-B（02170）2026年2月股份变动月报：股本维持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1128578366","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1128578366?lang=zh_cn&edition=full","pubTime":"2026-03-04 17:42","pubTimestamp":1772617374,"startTime":"0","endTime":"0","summary":"贝康医疗-B（02170）于2026年3月4日披露2026年2月证券变动月报表。报告显示，截至2026年2月28日，公司已发行股本及注册股本维持不变，未发生新增发行、购回或注销股份等变动。\n苏州贝康医疗股份有限公司目前拥有普通股合计273,526,000股（面值每股人民币1元）。其中，H股为82,713,835股，内资股为183,181,817股，未上市外资股为7,630,348股，均与上月末保持一致，库藏股数量也为零。\n公司说明已符合香港联交所对最低公众持股量的相关要求，并确认遵守《上市规则》及其他适用法规。本次公告由执行董事梁波签署。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02170"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614501758","title":"贝康医疗-B(02170)：Geri胚胎培养液(Gems胚胎培养液系列产品之一)获国家药监局颁发医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2614501758","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614501758?lang=zh_cn&edition=full","pubTime":"2026-02-26 18:51","pubTimestamp":1772103109,"startTime":"0","endTime":"0","summary":"智通财经APP讯，贝康医疗-B 发布公告，本公司的Geri胚胎培养液于2026年2月25日获得中国国家药品监督管理局颁发的三类医疗器械注册证。结合Geri湿式时差培养箱与AI胚胎评估系统，Geri胚胎培养液已正式进入中国临床实践，以其抗氧化配方与稳定渗透压环境的两大核心优势，解决了高龄患者胚胎培养的难题。Geri胚胎培养液的技术核心在于针对高龄患者生育难点构建系统性解决方案。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1407716.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["09997","BK1597","BK1222","BK1574","09996","BK1100","159883","BK1583","02170"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2613013785","title":"贝康医疗-B02月23日主力净流入11.6万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2613013785","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2613013785?lang=zh_cn&edition=full","pubTime":"2026-02-23 16:15","pubTimestamp":1771834553,"startTime":"0","endTime":"0","summary":"02月23日, 贝康医疗-B股价涨3.87%，报收1.88元，成交金额64.7万元，换手率0.43%，振幅3.31%，量比1.77。贝康医疗-B今日主力资金净流入11.6万元，上一交易日主力净流出0万元。该股近5个交易日下跌2.08%，主力资金累计净流入25.4万元；近20日主力资金累计净流出6.4万元，其中净流出天数为4日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260223162000a4be73dc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260223162000a4be73dc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","BK1222","BK1597","02170"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1143494261","title":"苏州贝康医疗（02170）2026年1月无新增发行或股份变动","url":"https://stock-news.laohu8.com/highlight/detail?id=1143494261","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1143494261?lang=zh_cn&edition=full","pubTime":"2026-02-04 17:06","pubTimestamp":1770196001,"startTime":"0","endTime":"0","summary":"苏州贝康医疗股份有限公司于2026年2月4日发布2026年1月股份变动月报表，披露截至2026年1月31日的股本结构及变动情况。公司目前注册及已发行股本包括：H股82,713,835股、内资股183,181,817股以及未上市外资股7,630,348股，各类股份自上月以来均未出现新增发行或购回注销情况，总股本维持在273,526,000股。公司表示已遵守香港联交所《上市规则》的相关规定要求，确认截至2026年1月31日的H股公众持股量满足上市规则标准。本次月报表由执行董事梁波签署。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02170"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2603601225","title":"贝康医疗-B(02170)：凌洋辞任非执行董事","url":"https://stock-news.laohu8.com/highlight/detail?id=2603601225","media":"智通财经网","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603601225?lang=zh_cn&edition=full","pubTime":"2026-01-15 19:38","pubTimestamp":1768477096,"startTime":"0","endTime":"0","summary":"智通财经APP讯，贝康医疗-B(02170)公布，凌洋先生因个人工作安排，提呈辞任非执行董事，自2026年1月15 日起生效。更多港股重磅资讯，下载智通财经app更多港股及海外理财资讯，请点击www.zhitongcaijing.com（搜索“智通财经”）；欲加入智通港股投资群，请加智通客服微信(ztcjkf)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1393458.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BK1597","BK1574","BK1222","02170"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1183689675","title":"苏州贝康医疗（2170）12月月报：股本结构稳定 未见新增发行或回购","url":"https://stock-news.laohu8.com/highlight/detail?id=1183689675","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1183689675?lang=zh_cn&edition=full","pubTime":"2026-01-06 16:36","pubTimestamp":1767688587,"startTime":"0","endTime":"0","summary":"苏州贝康医疗股份有限公司于2026年1月6日发布截至2025年12月31日的月度股份变动报告。公告显示，本月公司已发行H股、内资股及未上市外资股数量均无新增或减少，相关股本结构维持稳定。与上月相比，各类股份数量及已发行总股本并未发生变化。公司强调，已遵守香港联交所的相关上市规则及法律要求。公告由执行董事梁波签署。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02170"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2601838004","title":"贝康医疗-B01月05日主力净流出10.4万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2601838004","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601838004?lang=zh_cn&edition=full","pubTime":"2026-01-05 16:15","pubTimestamp":1767600957,"startTime":"0","endTime":"0","summary":"01月05日, 贝康医疗-B股价跌1.02%，报收1.95元，成交金额28.0万元，换手率0.17%，振幅6.60%，量比0.41。贝康医疗-B今日主力资金净流出10.4万元，上一交易日主力净流出0万元。该股近5个交易日下跌3.94%，主力资金累计净流出43.5万元；近20日主力资金累计净流出43.5万元，其中净流出天数为2日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260105162256a6f51540&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260105162256a6f51540&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1597","02170","BK1222","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2600606320","title":"贝康医疗-B盘中异动 快速上涨5.38%报1.960港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2600606320","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2600606320?lang=zh_cn&edition=full","pubTime":"2026-01-02 15:50","pubTimestamp":1767340218,"startTime":"0","endTime":"0","summary":"2026年01月02日临近收盘15时50分，贝康医疗-B股票出现波动，股价急速上涨5.38%。截至发稿，该股报1.960港元/股，成交量7.75万股，换手率0.09%，振幅3.23%。资金方面，该股资金流入8.4115万港元，流出5.085万港元。贝康医疗-B股票所在的生物技术行业中，整体涨幅为1.71%。其相关个股中，圣诺医药-B、晶泰控股、荃信生物-B涨幅较大，振幅较大的相关个股有拨康视云-B、轩竹生物-B、华昊中天医药-B，振幅分别为14.42%、13.19%、13.09%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026010215501897a0f198&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026010215501897a0f198&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1222","BK1597","02170","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2595382287","title":"贝康医疗-B盘中异动 急速跳水5.91%","url":"https://stock-news.laohu8.com/highlight/detail?id=2595382287","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595382287?lang=zh_cn&edition=full","pubTime":"2025-12-29 13:08","pubTimestamp":1766984890,"startTime":"0","endTime":"0","summary":"2025年12月29日下午盘13时08分，贝康医疗-B股票出现异动，股价大幅跳水5.91%。截至发稿，该股报1.910港元/股，成交量28.25万股，换手率0.34%，振幅6.90%。贝康医疗-B股票所在的生物技术行业中，整体跌幅为0.41%。其相关个股中，云康集团、帝王国际投资、永泰生物-B涨幅较大，振幅较大的相关个股有百奥赛图-B、翰思艾泰-B、帝王国际投资，振幅分别为15.34%、14.15%、13.64%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251229130810a4849825&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251229130810a4849825&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1597","BK1574","02170","BK1222"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2593194324","title":"贝康医疗-B盘中异动 下午盘急速下挫5.34%","url":"https://stock-news.laohu8.com/highlight/detail?id=2593194324","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593194324?lang=zh_cn&edition=full","pubTime":"2025-12-23 13:57","pubTimestamp":1766469477,"startTime":"0","endTime":"0","summary":"2025年12月23日下午盘13时57分，贝康医疗-B股票出现异动，股价急速下跌5.34%。截至发稿，该股报1.950港元/股，成交量7.9万股，换手率0.10%，振幅5.34%。贝康医疗-B股票所在的生物技术行业中，整体跌幅为1.09%。贝康医疗-B公司简介：苏州贝康医疗股份有限公司是一家主要提供辅助生殖基因检测解决方案的中国投资控股公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025122313575797a09583&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025122313575797a09583&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02170","BK1574","BK1597","BK1222"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1144838028","title":"苏州贝康医疗（02170）更新11月股份变动月报表，股本维持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1144838028","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1144838028?lang=zh_cn&edition=full","pubTime":"2025-12-03 16:42","pubTimestamp":1764751341,"startTime":"0","endTime":"0","summary":"苏州贝康医疗股份有限公司于2025年12月3日发布2025年11月的股份变动月报表。报告显示，截至2025年11月30日，公司未有新增股份发行或回购行为，各类股本结构维持不变。苏州贝康医疗在报告期内的H股已发行股份数目为82,713,835股，内资股为183,181,817股，未上市外资股为7,630,348股，三类股份数量较上个月均无变化，合计股本总数保持273,526,000股。根据月报显示，截至2025年11月底，公司整体股本持续保持稳定。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02170"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":0.05},{"period":"1month","weight":0.1351},{"period":"3month","weight":0.0244},{"period":"6month","weight":-0.2784},{"period":"1year","weight":-0.2759},{"period":"ytd","weight":0.129}],"compareEarnings":[{"period":"1week","weight":0.0237},{"period":"1month","weight":0.0191},{"period":"3month","weight":-0.0098},{"period":"6month","weight":-0.0151},{"period":"1year","weight":0.2864},{"period":"ytd","weight":0.0102}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"苏州贝康医疗股份有限公司（原名：江苏双螺旋生物科技有限公司）是一家主要提供辅助生殖基因检测解决方案的中国投资控股公司。该公司提供基因检测解决方案及销售基因检测设备及仪器。基因检测解决方案包括销售检测试剂盒及提供检测服务。该公司主要产品包括PGT-A试剂盒。该公司主要于国内市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.6,"avgChangeRate":0.002951},{"month":2,"riseRate":0.6,"avgChangeRate":0.105265},{"month":3,"riseRate":0.333333,"avgChangeRate":-0.100603},{"month":4,"riseRate":0.666667,"avgChangeRate":0.022467},{"month":5,"riseRate":0.2,"avgChangeRate":-0.07001},{"month":6,"riseRate":0.2,"avgChangeRate":-0.028295},{"month":7,"riseRate":0.4,"avgChangeRate":-0.049384},{"month":8,"riseRate":0.4,"avgChangeRate":-0.045091},{"month":9,"riseRate":0.4,"avgChangeRate":-0.013645},{"month":10,"riseRate":0.4,"avgChangeRate":0.015037},{"month":11,"riseRate":0.2,"avgChangeRate":-0.017242},{"month":12,"riseRate":0.2,"avgChangeRate":-0.11073}],"exchange":"SEHK","name":"贝康医疗-B","nameEN":"BASECARE-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.40.0","shortVersion":"4.40.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"贝康医疗-B(02170)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供贝康医疗-B(02170)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"贝康医疗-B,02170,贝康医疗-B股票,贝康医疗-B股票老虎,贝康医疗-B股票老虎国际,贝康医疗-B行情,贝康医疗-B股票行情,贝康医疗-B股价,贝康医疗-B股市,贝康医疗-B股票价格,贝康医疗-B股票交易,贝康医疗-B股票购买,贝康医疗-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"贝康医疗-B(02170)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供贝康医疗-B(02170)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}